Christopher Gibson - 27 Aug 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: RXRX
Reported as of: 27 Aug 2024
Net transaction value: +$12,400
SEC form: 4
Accepted by SEC: 27 Aug 2024, 16:10:34 UTC
Prior SEC filing: 26 Aug 2024
Next SEC filing: 28 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Golightly, attorney-in-fact

Key filing fact

Christopher Gibson filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 27 Aug 2024.

Key facts

This page summarizes Christopher Gibson's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
2 reported transactions and 9 derivative rows are listed below.
Accepted by SEC: 27 Aug 2024, 16:10.

Change

Previous filing in this sequence was filed on 26 Aug 2024.
Current net transaction value: +$12,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXRX transaction

Class A Common Stock

Options Exercise

Transaction value: $12,400
Shares: +5,000
Change %: +0.67%
Price: $2.48
Shares after: 747,656
Date: 27 Aug 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -5,000
Change %: -1.7%
Price: $0.000000
Shares after: 297,500
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,000
Exercise price: $2.48
Footnotes: F1

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,176,700
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F2

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 486,000
Date: 27 Aug 2024
Ownership: by LAHWRAN-3 LLC
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F2, F3

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 388,000
Date: 27 Aug 2024
Ownership: by LAHWRAN-4 LLC
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F2, F4

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 67,875
Date: 27 Aug 2024
Ownership: by Gibson Family Trust
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F2, F5

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 813,600
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $8.55
Footnotes: F6

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 399,002
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $11.40
Footnotes: F7

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,436
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $11.40

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 666,898
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $10.09
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Footnote F2

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Footnote F3

The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Footnote F4

The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Footnote F5

The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Footnote F6

The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F7

The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F8

The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .